nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisapride—Gefitinib—Lapatinib—breast cancer	0.413	1	CrCrCtD
Cisapride—CYP2D6—breast cancer	0.0734	0.538	CbGaD
Cisapride—CYP3A4—breast cancer	0.063	0.462	CbGaD
Cisapride—CYP2A6—Letrozole—breast cancer	0.0348	0.093	CbGbCtD
Cisapride—HTR2B—Raloxifene—breast cancer	0.0253	0.0675	CbGbCtD
Cisapride—CYP2B6—Thiotepa—breast cancer	0.0153	0.0409	CbGbCtD
Cisapride—CYP1A2—Anastrozole—breast cancer	0.0118	0.0316	CbGbCtD
Cisapride—CYP1A2—Toremifene—breast cancer	0.0108	0.0289	CbGbCtD
Cisapride—CYP2C9—Anastrozole—breast cancer	0.0107	0.0285	CbGbCtD
Cisapride—CYP3A5—Lapatinib—breast cancer	0.0106	0.0284	CbGbCtD
Cisapride—CYP2A6—Tamoxifen—breast cancer	0.0104	0.0277	CbGbCtD
Cisapride—CYP2B6—Raloxifene—breast cancer	0.0102	0.0273	CbGbCtD
Cisapride—CYP2C8—Lapatinib—breast cancer	0.0102	0.0273	CbGbCtD
Cisapride—CYP2C19—Lapatinib—breast cancer	0.00857	0.0229	CbGbCtD
Cisapride—CYP3A4—Exemestane—breast cancer	0.00819	0.0219	CbGbCtD
Cisapride—CYP2C9—Idarubicin—breast cancer	0.00809	0.0216	CbGbCtD
Cisapride—CYP2C8—Raloxifene—breast cancer	0.00774	0.0207	CbGbCtD
Cisapride—CYP2A6—Fluorouracil—breast cancer	0.00764	0.0204	CbGbCtD
Cisapride—CYP2D6—Idarubicin—breast cancer	0.0074	0.0198	CbGbCtD
Cisapride—CYP3A7—Tamoxifen—breast cancer	0.00709	0.0189	CbGbCtD
Cisapride—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.00709	0.0189	CbGbCtD
Cisapride—CYP3A4—Letrozole—breast cancer	0.00696	0.0186	CbGbCtD
Cisapride—CYP2B6—Tamoxifen—breast cancer	0.00675	0.018	CbGbCtD
Cisapride—CYP3A4—Anastrozole—breast cancer	0.00621	0.0166	CbGbCtD
Cisapride—CYP3A4—Toremifene—breast cancer	0.00568	0.0152	CbGbCtD
Cisapride—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.00552	0.0147	CbGbCtD
Cisapride—CYP3A7—Paclitaxel—breast cancer	0.00552	0.0147	CbGbCtD
Cisapride—CYP3A7—Irinotecan—breast cancer	0.00544	0.0145	CbGbCtD
Cisapride—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.00544	0.0145	CbGbCtD
Cisapride—CYP3A5—Tamoxifen—breast cancer	0.00532	0.0142	CbGbCtD
Cisapride—CYP3A4—Fulvestrant—breast cancer	0.00528	0.0141	CbGbCtD
Cisapride—CYP2B6—Irinotecan—breast cancer	0.00518	0.0138	CbGbCtD
Cisapride—CYP2C8—Tamoxifen—breast cancer	0.00511	0.0137	CbGbCtD
Cisapride—CYP3A4—Thiotepa—breast cancer	0.0047	0.0126	CbGbCtD
Cisapride—CYP2C9—Capecitabine—breast cancer	0.00443	0.0118	CbGbCtD
Cisapride—CYP3A4—Ixabepilone—breast cancer	0.0043	0.0115	CbGbCtD
Cisapride—CYP2C19—Tamoxifen—breast cancer	0.00429	0.0115	CbGbCtD
Cisapride—CYP3A4—Lapatinib—breast cancer	0.00414	0.0111	CbGbCtD
Cisapride—CYP3A5—Paclitaxel—breast cancer	0.00414	0.0111	CbGbCtD
Cisapride—CYP3A5—Irinotecan—breast cancer	0.00408	0.0109	CbGbCtD
Cisapride—CYP3A7—Docetaxel—breast cancer	0.00399	0.0107	CbGbCtD
Cisapride—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.00399	0.0107	CbGbCtD
Cisapride—CYP2C8—Paclitaxel—breast cancer	0.00398	0.0106	CbGbCtD
Cisapride—CYP1A2—Tamoxifen—breast cancer	0.00396	0.0106	CbGbCtD
Cisapride—CYP2C8—Fluorouracil—breast cancer	0.00377	0.0101	CbGbCtD
Cisapride—CYP2D6—Vinorelbine—breast cancer	0.00361	0.00965	CbGbCtD
Cisapride—CYP2C9—Tamoxifen—breast cancer	0.00357	0.00952	CbGbCtD
Cisapride—CYP2D6—Tamoxifen—breast cancer	0.00326	0.00871	CbGbCtD
Cisapride—CYP3A4—Raloxifene—breast cancer	0.00314	0.00838	CbGbCtD
Cisapride—CYP3A5—Docetaxel—breast cancer	0.00299	0.00799	CbGbCtD
Cisapride—CYP1A2—Fluorouracil—breast cancer	0.00292	0.00779	CbGbCtD
Cisapride—CYP2B6—Doxorubicin—breast cancer	0.00283	0.00756	CbGbCtD
Cisapride—CYP2C9—Paclitaxel—breast cancer	0.00278	0.00741	CbGbCtD
Cisapride—CYP2C9—Fluorouracil—breast cancer	0.00263	0.00702	CbGbCtD
Cisapride—CYP3A4—Vinorelbine—breast cancer	0.0023	0.00613	CbGbCtD
Cisapride—CYP2D6—Vinblastine—breast cancer	0.00223	0.00594	CbGbCtD
Cisapride—CYP3A4—Tamoxifen—breast cancer	0.00207	0.00554	CbGbCtD
Cisapride—CYP3A4—Mitoxantrone—breast cancer	0.00202	0.0054	CbGbCtD
Cisapride—CYP3A4—Paclitaxel—breast cancer	0.00161	0.00431	CbGbCtD
Cisapride—CYP3A4—Irinotecan—breast cancer	0.00159	0.00425	CbGbCtD
Cisapride—CYP3A4—Vinblastine—breast cancer	0.00142	0.00378	CbGbCtD
Cisapride—CYP2D6—Doxorubicin—breast cancer	0.00137	0.00365	CbGbCtD
Cisapride—CYP3A4—Docetaxel—breast cancer	0.00117	0.00312	CbGbCtD
Cisapride—CYP3A4—Doxorubicin—breast cancer	0.00087	0.00232	CbGbCtD
Cisapride—HTR4—pituitary gland—breast cancer	0.000861	0.103	CbGeAlD
Cisapride—HTR4—adrenal gland—breast cancer	0.000769	0.0916	CbGeAlD
Cisapride—Gefitinib—CHEK2—breast cancer	0.000545	0.204	CrCbGaD
Cisapride—Gefitinib—ERBB3—breast cancer	0.000486	0.182	CrCbGaD
Cisapride—Metoclopramide—CYP17A1—breast cancer	0.000458	0.172	CrCbGaD
Cisapride—CYP2C8—mammary gland—breast cancer	0.000284	0.0338	CbGeAlD
Cisapride—KCNH2—nipple—breast cancer	0.000256	0.0305	CbGeAlD
Cisapride—CYP3A7—endocrine gland—breast cancer	0.000255	0.0303	CbGeAlD
Cisapride—CYP2C9—mammary gland—breast cancer	0.000252	0.03	CbGeAlD
Cisapride—CYP2A6—adipose tissue—breast cancer	0.000227	0.0271	CbGeAlD
Cisapride—CYP1A2—nipple—breast cancer	0.00022	0.0261	CbGeAlD
Cisapride—Gefitinib—EGFR—breast cancer	0.000218	0.0817	CrCbGaD
Cisapride—HTR2B—skin of body—breast cancer	0.000206	0.0245	CbGeAlD
Cisapride—HTR2B—endometrium—breast cancer	0.000194	0.0231	CbGeAlD
Cisapride—HTR2B—uterus—breast cancer	0.000179	0.0213	CbGeAlD
Cisapride—HTR2B—adipose tissue—breast cancer	0.000175	0.0208	CbGeAlD
Cisapride—HTR2C—female reproductive system—breast cancer	0.000171	0.0204	CbGeAlD
Cisapride—HTR2B—female reproductive system—breast cancer	0.000161	0.0191	CbGeAlD
Cisapride—Gefitinib—ABCG2—breast cancer	0.000159	0.0597	CrCbGaD
Cisapride—HTR2B—adrenal gland—breast cancer	0.000157	0.0187	CbGeAlD
Cisapride—KCNH2—endometrium—breast cancer	0.000155	0.0184	CbGeAlD
Cisapride—KCNH2—uterus—breast cancer	0.000143	0.017	CbGeAlD
Cisapride—DRD2—pituitary gland—breast cancer	0.000142	0.0169	CbGeAlD
Cisapride—CYP2C8—endometrium—breast cancer	0.000142	0.0169	CbGeAlD
Cisapride—HTR2A—embryo—breast cancer	0.000142	0.0169	CbGeAlD
Cisapride—KCNH2—pituitary gland—breast cancer	0.00014	0.0167	CbGeAlD
Cisapride—CYP2B6—skin of body—breast cancer	0.000135	0.016	CbGeAlD
Cisapride—Iloperidone—CYP2D6—breast cancer	0.000129	0.0483	CrCbGaD
Cisapride—KCNH2—female reproductive system—breast cancer	0.000128	0.0153	CbGeAlD
Cisapride—CYP2C8—pituitary gland—breast cancer	0.000128	0.0153	CbGeAlD
Cisapride—Metoclopramide—CYP2D6—breast cancer	0.000128	0.0479	CrCbGaD
Cisapride—KCNH2—adrenal gland—breast cancer	0.000125	0.0149	CbGeAlD
Cisapride—Gefitinib—CYP1A1—breast cancer	0.000125	0.0468	CrCbGaD
Cisapride—KCNH2—bone marrow—breast cancer	0.000121	0.0144	CbGeAlD
Cisapride—CYP2C8—female reproductive system—breast cancer	0.000117	0.014	CbGeAlD
Cisapride—KCNH2—female gonad—breast cancer	0.000117	0.0139	CbGeAlD
Cisapride—HTR2A—epithelium—breast cancer	0.000116	0.0138	CbGeAlD
Cisapride—CYP3A5—adipose tissue—breast cancer	0.000115	0.0137	CbGeAlD
Cisapride—CYP2C19—endocrine gland—breast cancer	0.000114	0.0135	CbGeAlD
Cisapride—Iloperidone—CYP3A4—breast cancer	0.00011	0.0414	CrCbGaD
Cisapride—DRD2—endocrine gland—breast cancer	0.00011	0.0131	CbGeAlD
Cisapride—KCNH2—endocrine gland—breast cancer	0.000109	0.0129	CbGeAlD
Cisapride—CYP2B6—female reproductive system—breast cancer	0.000105	0.0125	CbGeAlD
Cisapride—CYP2C9—female reproductive system—breast cancer	0.000104	0.0124	CbGeAlD
Cisapride—CYP2B6—adrenal gland—breast cancer	0.000103	0.0122	CbGeAlD
Cisapride—CYP2C8—endocrine gland—breast cancer	9.93e-05	0.0118	CbGeAlD
Cisapride—CYP3A5—female gonad—breast cancer	9.64e-05	0.0115	CbGeAlD
Cisapride—HTR2B—lymph node—breast cancer	9.4e-05	0.0112	CbGeAlD
Cisapride—HTR2A—pituitary gland—breast cancer	9.38e-05	0.0112	CbGeAlD
Cisapride—CYP1A2—endocrine gland—breast cancer	9.29e-05	0.0111	CbGeAlD
Cisapride—Gefitinib—CYP2D6—breast cancer	9.27e-05	0.0348	CrCbGaD
Cisapride—CYP3A5—endocrine gland—breast cancer	8.96e-05	0.0107	CbGeAlD
Cisapride—CYP2B6—endocrine gland—breast cancer	8.91e-05	0.0106	CbGeAlD
Cisapride—CYP2C9—endocrine gland—breast cancer	8.82e-05	0.0105	CbGeAlD
Cisapride—HTR2A—female reproductive system—breast cancer	8.58e-05	0.0102	CbGeAlD
Cisapride—HTR2A—adrenal gland—breast cancer	8.38e-05	0.00998	CbGeAlD
Cisapride—Gefitinib—CYP3A4—breast cancer	7.95e-05	0.0298	CrCbGaD
Cisapride—CYP3A4—female reproductive system—breast cancer	7.95e-05	0.00946	CbGeAlD
Cisapride—CYP2D6—female reproductive system—breast cancer	7.82e-05	0.00931	CbGeAlD
Cisapride—KCNH2—lymph node—breast cancer	7.5e-05	0.00893	CbGeAlD
Cisapride—HTR2A—endocrine gland—breast cancer	7.26e-05	0.00865	CbGeAlD
Cisapride—CYP2D6—female gonad—breast cancer	7.12e-05	0.00847	CbGeAlD
Cisapride—Gefitinib—ALB—breast cancer	6.94e-05	0.026	CrCbGaD
Cisapride—CYP3A4—endocrine gland—breast cancer	6.73e-05	0.00801	CbGeAlD
Cisapride—Gefitinib—ABCB1—breast cancer	6.62e-05	0.0248	CrCbGaD
Cisapride—CYP2D6—endocrine gland—breast cancer	6.62e-05	0.00788	CbGeAlD
Cisapride—CYP2D6—Metabolism—ERCC2—breast cancer	1.42e-06	2.17e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CYP1A1—breast cancer	1.42e-06	2.17e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PIK3CD—breast cancer	1.42e-06	2.17e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—ERBB2—breast cancer	1.42e-06	2.16e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PIK3CD—breast cancer	1.41e-06	2.16e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.41e-06	2.16e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—ERCC2—breast cancer	1.41e-06	2.15e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—ALB—breast cancer	1.4e-06	2.14e-05	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—PIK3CA—breast cancer	1.4e-06	2.14e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—COMT—breast cancer	1.4e-06	2.14e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—NCOA2—breast cancer	1.4e-06	2.14e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—SERPINE1—breast cancer	1.4e-06	2.14e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MTOR—breast cancer	1.4e-06	2.14e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PIK3CB—breast cancer	1.4e-06	2.14e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—GSTP1—breast cancer	1.39e-06	2.13e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PIK3CD—breast cancer	1.39e-06	2.13e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PIK3CD—breast cancer	1.39e-06	2.12e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—SRC—breast cancer	1.39e-06	2.12e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—KRAS—breast cancer	1.39e-06	2.12e-05	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—PIK3CA—breast cancer	1.38e-06	2.11e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—SERPINE1—breast cancer	1.38e-06	2.1e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—HMOX1—breast cancer	1.37e-06	2.1e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—ITPR1—breast cancer	1.37e-06	2.1e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—ALB—breast cancer	1.37e-06	2.09e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PIK3CG—breast cancer	1.37e-06	2.09e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—KRAS—breast cancer	1.36e-06	2.08e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—FASN—breast cancer	1.36e-06	2.08e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—BCHE—breast cancer	1.35e-06	2.07e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—VEGFA—breast cancer	1.35e-06	2.07e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CXCL8—breast cancer	1.34e-06	2.05e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—NOS3—breast cancer	1.34e-06	2.05e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—CAV1—breast cancer	1.34e-06	2.05e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—STAT3—breast cancer	1.34e-06	2.05e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—MTHFR—breast cancer	1.34e-06	2.04e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—NOS3—breast cancer	1.34e-06	2.04e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—SLC5A5—breast cancer	1.34e-06	2.04e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—HRAS—breast cancer	1.33e-06	2.04e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PTEN—breast cancer	1.33e-06	2.03e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—MTHFR—breast cancer	1.32e-06	2.03e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—ABCB1—breast cancer	1.32e-06	2.02e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—NOS3—breast cancer	1.31e-06	2.01e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CDKN1B—breast cancer	1.31e-06	2e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—NOS3—breast cancer	1.31e-06	2e-05	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—AKT1—breast cancer	1.3e-06	1.98e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—TYMS—breast cancer	1.3e-06	1.98e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—NQO1—breast cancer	1.29e-06	1.97e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—SLC2A1—breast cancer	1.29e-06	1.97e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CASP3—breast cancer	1.29e-06	1.96e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—IL2—breast cancer	1.28e-06	1.96e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—NCOR1—breast cancer	1.28e-06	1.96e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PLA2G4A—breast cancer	1.28e-06	1.96e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—GSTM1—breast cancer	1.28e-06	1.96e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.28e-06	1.96e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—MAPK3—breast cancer	1.28e-06	1.95e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—IL6—breast cancer	1.28e-06	1.95e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—PIK3CA—breast cancer	1.27e-06	1.95e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MDM2—breast cancer	1.27e-06	1.94e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—RAF1—breast cancer	1.26e-06	1.93e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—RELA—breast cancer	1.26e-06	1.92e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—PIK3CA—breast cancer	1.25e-06	1.91e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CCND1—breast cancer	1.25e-06	1.91e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—ERBB2—breast cancer	1.25e-06	1.91e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—JUN—breast cancer	1.25e-06	1.91e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MDM2—breast cancer	1.25e-06	1.91e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—MYC—breast cancer	1.24e-06	1.9e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—RAF1—breast cancer	1.24e-06	1.9e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—TGFB1—breast cancer	1.24e-06	1.9e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CTNNB1—breast cancer	1.24e-06	1.89e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PIK3CB—breast cancer	1.24e-06	1.89e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—RELA—breast cancer	1.24e-06	1.89e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CYP1B1—breast cancer	1.24e-06	1.89e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MTOR—breast cancer	1.23e-06	1.89e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PIK3CB—breast cancer	1.23e-06	1.89e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—CAV1—breast cancer	1.23e-06	1.88e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—ERBB2—breast cancer	1.23e-06	1.88e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—GPX1—breast cancer	1.23e-06	1.88e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PTGS2—breast cancer	1.23e-06	1.87e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CAV1—breast cancer	1.22e-06	1.87e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PIK3CG—breast cancer	1.22e-06	1.87e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—EGFR—breast cancer	1.22e-06	1.86e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MMP9—breast cancer	1.21e-06	1.86e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CYP1A1—breast cancer	1.21e-06	1.86e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MTOR—breast cancer	1.21e-06	1.85e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PIK3CB—breast cancer	1.21e-06	1.85e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.21e-06	1.85e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CDKN1A—breast cancer	1.21e-06	1.85e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PIK3CB—breast cancer	1.21e-06	1.85e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PTEN—breast cancer	1.21e-06	1.85e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—ERCC2—breast cancer	1.2e-06	1.84e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PIK3CD—breast cancer	1.2e-06	1.84e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PTGS2—breast cancer	1.2e-06	1.83e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—ALB—breast cancer	1.19e-06	1.81e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CXCL8—breast cancer	1.19e-06	1.81e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MAPK8—breast cancer	1.18e-06	1.81e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—NCOA1—breast cancer	1.18e-06	1.8e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—AKT1—breast cancer	1.18e-06	1.8e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—HRAS—breast cancer	1.18e-06	1.8e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.17e-06	1.78e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CXCL8—breast cancer	1.17e-06	1.78e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—STK11—breast cancer	1.16e-06	1.78e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CYP19A1—breast cancer	1.16e-06	1.78e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—HRAS—breast cancer	1.16e-06	1.77e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CDKN1B—breast cancer	1.16e-06	1.77e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—KRAS—breast cancer	1.15e-06	1.76e-05	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—AKT1—breast cancer	1.14e-06	1.75e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CDKN1B—breast cancer	1.14e-06	1.74e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—NOS3—breast cancer	1.14e-06	1.74e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CASP3—breast cancer	1.13e-06	1.73e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IL2—breast cancer	1.13e-06	1.73e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—MTHFR—breast cancer	1.13e-06	1.73e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—IL6—breast cancer	1.13e-06	1.72e-05	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—AKT1—breast cancer	1.13e-06	1.72e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PIK3CG—breast cancer	1.12e-06	1.72e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—SRC—breast cancer	1.12e-06	1.71e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CASP3—breast cancer	1.12e-06	1.71e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IL2—breast cancer	1.11e-06	1.7e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PIK3CG—breast cancer	1.11e-06	1.7e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—IL6—breast cancer	1.11e-06	1.69e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CCND1—breast cancer	1.1e-06	1.69e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—JUN—breast cancer	1.1e-06	1.68e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CTNNB1—breast cancer	1.09e-06	1.67e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—VEGFA—breast cancer	1.09e-06	1.67e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CCND1—breast cancer	1.09e-06	1.66e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—JUN—breast cancer	1.08e-06	1.66e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—COMT—breast cancer	1.08e-06	1.65e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—STAT3—breast cancer	1.08e-06	1.65e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CTNNB1—breast cancer	1.08e-06	1.64e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GSTP1—breast cancer	1.08e-06	1.64e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PIK3CD—breast cancer	1.07e-06	1.64e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MMP9—breast cancer	1.07e-06	1.64e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PTEN—breast cancer	1.07e-06	1.63e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CDKN1A—breast cancer	1.07e-06	1.63e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PTEN—breast cancer	1.07e-06	1.63e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—HMOX1—breast cancer	1.06e-06	1.62e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—ALB—breast cancer	1.06e-06	1.62e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—ITPR1—breast cancer	1.06e-06	1.62e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—PIK3CA—breast cancer	1.06e-06	1.61e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MMP9—breast cancer	1.05e-06	1.61e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CDKN1A—breast cancer	1.05e-06	1.61e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PTEN—breast cancer	1.05e-06	1.6e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PIK3CB—breast cancer	1.05e-06	1.6e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PTEN—breast cancer	1.05e-06	1.6e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CAV1—breast cancer	1.04e-06	1.6e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MAPK8—breast cancer	1.04e-06	1.59e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—AKT1—breast cancer	1.04e-06	1.59e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PTGS2—breast cancer	1.04e-06	1.59e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MAPK3—breast cancer	1.03e-06	1.58e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MAPK8—breast cancer	1.03e-06	1.57e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—AKT1—breast cancer	1.02e-06	1.56e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—TP53—breast cancer	1.02e-06	1.56e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PIK3CA—breast cancer	1.02e-06	1.56e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—ABCB1—breast cancer	1.02e-06	1.56e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—NOS3—breast cancer	1.01e-06	1.55e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MYC—breast cancer	1e-06	1.53e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—TGFB1—breast cancer	1e-06	1.53e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—TYMS—breast cancer	1e-06	1.53e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	9.98e-07	1.52e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PLA2G4A—breast cancer	9.89e-07	1.51e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—NCOR1—breast cancer	9.89e-07	1.51e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GSTM1—breast cancer	9.89e-07	1.51e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—SRC—breast cancer	9.88e-07	1.51e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PIK3CD—breast cancer	9.87e-07	1.51e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—EGFR—breast cancer	9.81e-07	1.5e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PIK3CD—breast cancer	9.78e-07	1.5e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—HRAS—breast cancer	9.77e-07	1.49e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—ALB—breast cancer	9.74e-07	1.49e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—SRC—breast cancer	9.72e-07	1.49e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—ALB—breast cancer	9.66e-07	1.48e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—VEGFA—breast cancer	9.62e-07	1.47e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—STAT3—breast cancer	9.53e-07	1.46e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PIK3CG—breast cancer	9.51e-07	1.45e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—VEGFA—breast cancer	9.47e-07	1.45e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GPX1—breast cancer	9.47e-07	1.45e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—STAT3—breast cancer	9.38e-07	1.43e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CYP1A1—breast cancer	9.37e-07	1.43e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PIK3CB—breast cancer	9.35e-07	1.43e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PIK3CA—breast cancer	9.35e-07	1.43e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—IL6—breast cancer	9.35e-07	1.43e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—NOS3—breast cancer	9.32e-07	1.42e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—ERCC2—breast cancer	9.29e-07	1.42e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—KRAS—breast cancer	9.27e-07	1.42e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PTGS2—breast cancer	9.27e-07	1.42e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—NOS3—breast cancer	9.24e-07	1.41e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MAPK3—breast cancer	9.11e-07	1.39e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PTEN—breast cancer	9.05e-07	1.38e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MAPK3—breast cancer	8.96e-07	1.37e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MYC—breast cancer	8.86e-07	1.35e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TGFB1—breast cancer	8.83e-07	1.35e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—MTHFR—breast cancer	8.74e-07	1.34e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MYC—breast cancer	8.71e-07	1.33e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TGFB1—breast cancer	8.69e-07	1.33e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—EGFR—breast cancer	8.66e-07	1.32e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—AKT1—breast cancer	8.63e-07	1.32e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PIK3CB—breast cancer	8.6e-07	1.32e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PIK3CB—breast cancer	8.53e-07	1.3e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PTGS2—breast cancer	8.52e-07	1.3e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—EGFR—breast cancer	8.52e-07	1.3e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PIK3CA—breast cancer	8.52e-07	1.3e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PTGS2—breast cancer	8.45e-07	1.29e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PIK3CD—breast cancer	8.36e-07	1.28e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—AKT1—breast cancer	8.33e-07	1.27e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—ALB—breast cancer	8.25e-07	1.26e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—TP53—breast cancer	8.24e-07	1.26e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—KRAS—breast cancer	8.18e-07	1.25e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PTEN—breast cancer	8.08e-07	1.24e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CAV1—breast cancer	8.06e-07	1.23e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—KRAS—breast cancer	8.05e-07	1.23e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—NOS3—breast cancer	7.9e-07	1.21e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—HRAS—breast cancer	7.88e-07	1.2e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—AKT1—breast cancer	7.64e-07	1.17e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PIK3CA—breast cancer	7.55e-07	1.15e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—IL6—breast cancer	7.54e-07	1.15e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PIK3CA—breast cancer	7.52e-07	1.15e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PTEN—breast cancer	7.43e-07	1.14e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PIK3CA—breast cancer	7.4e-07	1.13e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PIK3CA—breast cancer	7.38e-07	1.13e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PTEN—breast cancer	7.37e-07	1.13e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PIK3CG—breast cancer	7.34e-07	1.12e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PIK3CB—breast cancer	7.29e-07	1.11e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TP53—breast cancer	7.27e-07	1.11e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PTGS2—breast cancer	7.22e-07	1.1e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TP53—breast cancer	7.16e-07	1.09e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—AKT1—breast cancer	6.96e-07	1.06e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—HRAS—breast cancer	6.96e-07	1.06e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—HRAS—breast cancer	6.84e-07	1.05e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IL6—breast cancer	6.66e-07	1.02e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IL6—breast cancer	6.55e-07	1e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PIK3CD—breast cancer	6.45e-07	9.86e-06	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PIK3CA—breast cancer	6.39e-07	9.76e-06	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—ALB—breast cancer	6.37e-07	9.74e-06	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PTEN—breast cancer	6.3e-07	9.63e-06	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—AKT1—breast cancer	6.16e-07	9.42e-06	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—AKT1—breast cancer	6.14e-07	9.39e-06	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—NOS3—breast cancer	6.09e-07	9.31e-06	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—AKT1—breast cancer	6.04e-07	9.24e-06	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—AKT1—breast cancer	6.02e-07	9.21e-06	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PIK3CA—breast cancer	5.7e-07	8.72e-06	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PIK3CB—breast cancer	5.62e-07	8.6e-06	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PTGS2—breast cancer	5.57e-07	8.52e-06	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PIK3CA—breast cancer	5.24e-07	8.02e-06	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—AKT1—breast cancer	5.22e-07	7.98e-06	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PIK3CA—breast cancer	5.2e-07	7.95e-06	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PTEN—breast cancer	4.86e-07	7.43e-06	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—AKT1—breast cancer	4.66e-07	7.12e-06	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PIK3CA—breast cancer	4.44e-07	6.79e-06	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—AKT1—breast cancer	4.28e-07	6.55e-06	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—AKT1—breast cancer	4.25e-07	6.49e-06	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—AKT1—breast cancer	3.63e-07	5.55e-06	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PIK3CA—breast cancer	3.43e-07	5.24e-06	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—AKT1—breast cancer	2.8e-07	4.28e-06	CbGpPWpGaD
